Anirvan Ghosh insider trades: Unity Biotechnology (UBX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Anirvan reports to the SEC
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 2, 2025 | UBX | ↓ Sell | 96,797 | $1.03 | $100K | Direct | Apr 3, 2025 (1d) |
| Feb 4, 2025 | UBX | ↓ Sell | 642 | $2.23 | $1K | Direct | Feb 5, 2025 (1d) |
| Nov 4, 2024 | UBX | ↓ Sell | 432 | $1.29 | $557 | Direct | Nov 6, 2024 (2d) |
| Aug 2, 2024 | UBX | ↓ Sell | 604 | $1.53 | $924 | Direct | Aug 6, 2024 (4d) |
| Jun 25, 2024 | UBX | ↓ Sell | 1,214 | $1.40 | $2K | Direct | Jun 26, 2024 (1d) |
| May 2, 2024 | UBX | ↓ Sell | 603 | $1.55 | $935 | Direct | May 3, 2024 (1d) |
| Feb 2, 2024 | UBX | ↓ Sell | 680 | $1.71 | $1K | Direct | Feb 5, 2024 (3d) |
| Jan 30, 2024 | UBX | ↓ Sell | 1,183 | $1.71 | $2K | Direct | Jan 31, 2024 (1d) |
| Nov 2, 2023 | UBX | ↓ Sell | 589 | $1.83 | $1K | Direct | Nov 3, 2023 (1d) |
| Oct 30, 2023 | UBX | ↓ Sell | 1,024 | $1.90 | $2K | Direct | Oct 31, 2023 (1d) |
| Sep 14, 2023 | UBX | ↓ Sell | 1,246 | $2.47 | $3K | Direct | Sep 15, 2023 (1d) |
| Aug 2, 2023 | UBX | ↓ Sell | 581 | $2.94 | $2K | Direct | Aug 3, 2023 (1d) |
| Jul 31, 2023 | UBX | ↓ Sell | 1,020 | $2.86 | $3K | Direct | Aug 1, 2023 (1d) |
| Jun 26, 2023 | UBX | ↓ Sell | 1,177 | $3.20 | $4K | Direct | Jun 27, 2023 (1d) |
| Jun 14, 2023 | UBX | ↓ Sell | 1,212 | $3.39 | $4K | Direct | Jun 15, 2023 (1d) |
| May 2, 2023 | UBX | ↓ Sell | 588 | $2.17 | $1K | Direct | May 3, 2023 (1d) |
| May 1, 2023 | UBX | ↓ Sell | 1,020 | $2.15 | $2K | Direct | May 2, 2023 (1d) |
| Mar 31, 2023 | UBX | ↓ Sell | 1,959 | $1.70 | $3K | Direct | Apr 3, 2023 (3d) |
| Mar 14, 2023 | UBX | ↓ Sell | 1,210 | $4.00 | $5K | Direct | Mar 15, 2023 (1d) |
| Feb 2, 2023 | UBX | ↓ Sell | 2,573 | $4.84 | $12K | Direct | Feb 3, 2023 (1d) |
| Jan 30, 2023 | UBX | ↓ Sell | 1,140 | $4.45 | $5K | Direct | Jan 31, 2023 (1d) |
| Dec 14, 2022 | UBX | ↓ Sell | 1,274 | $2.85 | $4K | Direct | Dec 15, 2022 (1d) |
| Nov 3, 2022 | UBX | ↓ Sell | 1,099 | $2.40 | $3K | Direct | Nov 4, 2022 (1d) |
| Sep 14, 2022 | UBX | ↓ Sell | 13,706 | $0.48 | $7K | Direct | Sep 15, 2022 (1d) |
| Aug 1, 2022 | UBX | ↓ Sell | 10,446 | $0.67 | $7K | Direct | Aug 2, 2022 (1d) |
| Jun 27, 2022 | UBX | ↓ Sell | 12,149 | $0.59 | $7K | Direct | Jun 28, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Anirvan Ghosh's insider trades
Anirvan Ghosh is Chief Executive Officer at Unity Biotechnology (UBX). Since Jun 27, 2022, Anirvan has reported no open-market purchases and 26 sales worth $183K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (9 filings), shares withheld for taxes (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every UBX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.